CN102405051A - 一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 - Google Patents
一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 Download PDFInfo
- Publication number
- CN102405051A CN102405051A CN2011800012855A CN201180001285A CN102405051A CN 102405051 A CN102405051 A CN 102405051A CN 2011800012855 A CN2011800012855 A CN 2011800012855A CN 201180001285 A CN201180001285 A CN 201180001285A CN 102405051 A CN102405051 A CN 102405051A
- Authority
- CN
- China
- Prior art keywords
- hemoglobin
- oxygen
- cross
- carrier
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310054976.2A CN103169954B (zh) | 2010-05-27 | 2011-04-15 | 一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34876410P | 2010-05-27 | 2010-05-27 | |
US61/348,764 | 2010-05-27 | ||
US13/013,847 | 2011-01-26 | ||
US13/013,847 US8742073B2 (en) | 2010-05-27 | 2011-01-26 | Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
US13/083,639 | 2011-04-11 | ||
US13/083,639 US7989593B1 (en) | 2010-05-27 | 2011-04-11 | Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
PCT/US2011/032594 WO2011149602A1 (en) | 2010-05-27 | 2011-04-15 | High-temperature stable oxygen-carrier-containing pharmaceutical composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310054976.2A Division CN103169954B (zh) | 2010-05-27 | 2011-04-15 | 一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102405051A true CN102405051A (zh) | 2012-04-04 |
CN102405051B CN102405051B (zh) | 2013-01-23 |
Family
ID=44314337
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011800012855A Active CN102405051B (zh) | 2010-05-27 | 2011-04-15 | 一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 |
CN201310054976.2A Expired - Fee Related CN103169954B (zh) | 2010-05-27 | 2011-04-15 | 一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310054976.2A Expired - Fee Related CN103169954B (zh) | 2010-05-27 | 2011-04-15 | 一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 |
Country Status (21)
Country | Link |
---|---|
US (1) | US7989593B1 (zh) |
EP (1) | EP2411025B1 (zh) |
JP (1) | JP5261806B2 (zh) |
KR (1) | KR101185437B1 (zh) |
CN (2) | CN102405051B (zh) |
AR (1) | AR081222A1 (zh) |
AU (1) | AU2011221433B2 (zh) |
CA (1) | CA2752943C (zh) |
CY (1) | CY1115986T1 (zh) |
DK (1) | DK2411025T3 (zh) |
ES (1) | ES2527608T3 (zh) |
HK (2) | HK1160604A1 (zh) |
NZ (1) | NZ594915A (zh) |
PL (1) | PL2411025T3 (zh) |
PT (1) | PT2411025E (zh) |
RU (1) | RU2475252C1 (zh) |
SA (1) | SA111320476B1 (zh) |
SG (1) | SG182237A1 (zh) |
TW (1) | TWI377947B (zh) |
WO (1) | WO2011149602A1 (zh) |
ZA (1) | ZA201208726B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251998A (zh) * | 2012-11-08 | 2013-08-21 | 黄炳镠 | 用于血红蛋白氧载体(hboc)溶液的精确输注递送系统 |
CN104717966A (zh) * | 2012-10-12 | 2015-06-17 | 视界全球控股有限公司 | 用于癌症靶向治疗和预防癌症复发的含有基于血红蛋白的氧载体的药物组合物 |
CN106421805A (zh) * | 2016-09-14 | 2017-02-22 | 中国人民解放军军事医学科学院野战输血研究所 | 一种右旋糖酐交联血红蛋白氧载体及其制备方法与应用 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8048856B1 (en) * | 2010-06-23 | 2011-11-01 | Billion King, Ltd. | Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition |
US8084581B1 (en) | 2011-04-29 | 2011-12-27 | Bing Lou Wong | Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus |
US20130052232A1 (en) * | 2011-08-31 | 2013-02-28 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
US9066933B2 (en) | 2011-09-06 | 2015-06-30 | Billion King International Ltd. | Oral delivery for hemoglobin based oxygen carriers |
US10385116B2 (en) | 2013-01-07 | 2019-08-20 | Omniox, Inc. | Polymeric forms of H-NOX proteins |
EA032164B1 (ru) * | 2013-05-13 | 2019-04-30 | Вижн Глобал Холдингс Лтд. | Содержащая модифицированное лекарственное вещество на основе гемоглобина фармацевтическая композиция для таргетной терапии рака и диагностической визуализации |
US9814759B2 (en) | 2014-07-02 | 2017-11-14 | Cheer Global Ltd. | Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment |
BR112017019862A2 (pt) * | 2015-03-17 | 2018-05-29 | Omniox Inc | modulação de imunidade de tumor através de liberaçâo de o2 mediada por proteína |
US9763889B2 (en) | 2015-06-29 | 2017-09-19 | Billion King International Ltd. | Oral delivery system for hemoglobin based oxygen carriers |
US10052290B2 (en) | 2016-02-04 | 2018-08-21 | Billion King International Ltd. | Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers |
WO2020080978A2 (ru) * | 2018-10-19 | 2020-04-23 | Рахимджан Ахметджанович РОЗИЕВ | Cпособ получения кровезаменителя для применения в ветеринарии |
BR112022003751A2 (pt) * | 2019-08-29 | 2022-05-31 | Billion King Int Ltd | Análogos de hemoglobina reticulada com tiosuccinila e métodos de uso e preparação dos mesmos |
CN113621055B (zh) * | 2021-08-23 | 2023-05-02 | 山东仙普爱瑞科技股份有限公司 | 一种抗菌和抗病毒的猪血红蛋白β链C端片段、表达该片段的枯草芽孢杆菌、制剂以及应用 |
CA3231611A1 (en) * | 2021-09-17 | 2023-03-23 | Nenad SESTAN | Methods, systems and compositions for restoration and preservation of intact organs in a mammal |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250665A (en) * | 1991-05-31 | 1993-10-05 | The University Of Toronto Innovations Foundation | Specifically β-β cross-linked hemoglobins and method of preparation |
US5618919A (en) * | 1986-11-10 | 1997-04-08 | Biopure Corportion | Ultra pure hemoglobin solutions and blood-substitutes |
US6150506A (en) * | 1989-05-10 | 2000-11-21 | Baxter Biotech Technology Sarl | Modified hemoglobin-like compounds and methods of purifying same |
US7041800B1 (en) * | 1995-03-23 | 2006-05-09 | Biopure Corporation | Preserving a hemoglobin blood substitute with a transparent overwrap |
US20100035797A1 (en) * | 2006-10-23 | 2010-02-11 | IKOR Inc., a South Dakota Corporation | Nitric oxide-blocked cross-linked tetrameric hemoglobin |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4529719A (en) | 1983-05-04 | 1985-07-16 | Tye Ross W | Modified crosslinked stroma-free tetrameric hemoglobin |
FR2548671B1 (fr) | 1983-07-07 | 1986-05-02 | Merieux Inst | Procede de preparation de globine a partir d'hemoglobine et globine obtenue par ce procede |
US4831012A (en) | 1984-03-23 | 1989-05-16 | Baxter International Inc. | Purified hemoglobin solutions and method for making same |
US4600531A (en) | 1984-06-27 | 1986-07-15 | University Of Iowa Research Foundation | Production of alpha-alpha cross-linked hemoglobins in high yield |
US4598064A (en) | 1984-06-27 | 1986-07-01 | University Of Iowa Research Foundation | Alpha-alpha cross-linked hemoglobins |
USRE34271E (en) | 1984-06-27 | 1993-06-01 | University Of Iowa Research Foundation | Production of alpha-alpha cross-linked hemoglobins in high yield |
JPH0750329B2 (ja) | 1986-06-23 | 1995-05-31 | 富士写真フイルム株式会社 | 画像形成材料 |
US5753616A (en) | 1986-11-10 | 1998-05-19 | Biopure Corporation | Method for producing a stable polymerized hemoglobin blood-substitute |
US5955581A (en) | 1986-11-10 | 1999-09-21 | Biopure Corporation | Method for producing a stable polymerized hemoglobin blood-substitute |
US5084558A (en) | 1987-10-13 | 1992-01-28 | Biopure Corporation | Extra pure semi-synthetic blood substitute |
US5189146A (en) | 1987-05-05 | 1993-02-23 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Pasteurizable, freeze-driable hemoglobin-based blood substitute |
US5439882A (en) | 1989-12-29 | 1995-08-08 | Texas Tech University Health Sciences Center | Blood substitute |
US5344393A (en) | 1992-02-28 | 1994-09-06 | Alliance Pharmaceutical Corp. | Use of synthetic oxygen carriers to facilitate oxygen delivery |
US6187744B1 (en) | 1992-03-11 | 2001-02-13 | Michael W. Rooney | Methods and compositions for regulating the intravascular flow and oxygenating activity of hemoglobin in a human or animal subject |
US5399671A (en) * | 1992-11-18 | 1995-03-21 | Kluger; Ronald | Specifically crosslinked hemoglobin with free functionality |
US5840851A (en) | 1993-07-23 | 1998-11-24 | Plomer; J. Jeffrey | Purification of hemoglobin |
US5725839A (en) | 1993-08-16 | 1998-03-10 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI |
US5804561A (en) | 1993-08-16 | 1998-09-08 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
US5840701A (en) | 1993-08-16 | 1998-11-24 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
TW381022B (en) | 1993-08-16 | 2000-02-01 | Hsia Jen Chang | Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
US5741893A (en) | 1993-08-16 | 1998-04-21 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
US5767089A (en) | 1993-08-16 | 1998-06-16 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
US5824781A (en) | 1993-08-16 | 1998-10-20 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
US5807831A (en) | 1993-08-16 | 1998-09-15 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
US5817632A (en) | 1993-08-16 | 1998-10-06 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
US6242417B1 (en) | 1994-03-08 | 2001-06-05 | Somatogen, Inc. | Stabilized compositions containing hemoglobin |
US5631219A (en) | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
EP0804734B1 (en) | 1994-05-13 | 2005-05-04 | Miltenyi Biotec GmbH | Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
SE9500724D0 (sv) | 1994-06-23 | 1995-02-24 | Pharmacia Ab | Filtrering |
US6610832B1 (en) | 1995-03-23 | 2003-08-26 | Biopure Corporation | Preserving a hemoglobin blood substitute with a transparent overwrap |
ES2179188T3 (es) * | 1995-03-23 | 2003-01-16 | Biopure Corp | Sustituto de la sangre a base de hemoglobina polimerizada estable. |
US5895810A (en) | 1995-03-23 | 1999-04-20 | Biopure Corporation | Stable polymerized hemoglobin and use thereof |
US5865784A (en) | 1995-06-07 | 1999-02-02 | Alliance Pharmaceutical Corp. | Method of hemodilution facilitated by monitoring oxygenation status |
US5691453A (en) | 1995-06-07 | 1997-11-25 | Biopure Corporation | Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC |
WO1998034955A1 (en) * | 1997-02-06 | 1998-08-13 | Duke University Medical Center | No-modified hemoglobins and uses therefor |
CA2236794A1 (en) | 1995-11-30 | 1997-06-05 | Bruce A. Kerwin | Method for control of functionality during cross-linking of hemoglobins |
EP0892830B1 (de) | 1996-03-21 | 2003-08-13 | Kobusch-Sengewald GmbH & Co.KG | Mehrlagenfolie, verfahren zu ihrer herstellung und ihre verwendung |
JP2000509374A (ja) | 1996-04-19 | 2000-07-25 | アルファ セラピュティック コーポレイション | 凍結乾燥した血液タンパク質のウイルス不活性化方法 |
RU2080865C1 (ru) * | 1996-07-08 | 1997-06-10 | Станислав Людвигович Люблинский | Способ получения гемоглобина |
EP1011710B1 (en) | 1997-02-28 | 2005-08-17 | The Regents of the University of California | Methods and compositions for optimization of oxygen transport by cell-free systems |
US5814601A (en) | 1997-02-28 | 1998-09-29 | The Regents Of The University Of California | Methods and compositions for optimization of oxygen transport by cell-free systems |
AU745209B2 (en) | 1998-01-06 | 2002-03-14 | Cerus Corporation | Methods for quenching pathogen inactivators in biological materials |
CA2233725A1 (en) * | 1998-03-31 | 1999-09-30 | Hemosol Inc. | Hemoglobin-hydroxyethyl starch complexes |
US6894150B1 (en) | 1999-10-01 | 2005-05-17 | Ross Walden Tye | Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin |
US6747132B2 (en) | 2000-11-29 | 2004-06-08 | Apex Biosciences, Inc. | Methods for the synthesis of a modified hemoglobin solution |
US6518010B2 (en) | 2001-02-28 | 2003-02-11 | Biopure Corporation | Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
MXPA03009555A (es) | 2001-04-18 | 2004-12-06 | Northfield Lab | Sistema de recipiente flexible para almacenamiento de soluciones de hemoglobina estabilizadas. |
JP4260417B2 (ja) | 2001-05-23 | 2009-04-30 | ノバルティス アクチエンゲゼルシャフト | 溶液を輸送し脱酸素するためのシステム及び方法 |
US7038016B2 (en) | 2001-08-21 | 2006-05-02 | Apex Bioscience, Inc. | Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution |
US20030153491A1 (en) | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
US20050164915A1 (en) | 2002-04-01 | 2005-07-28 | Sangart, Inc. | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
AU2003299700B2 (en) | 2002-12-23 | 2009-03-26 | Albert Einstein College Of Medicine Of Yeshiva University | Modified hemoglobin and methods of making same |
EP1592437A4 (en) | 2003-01-29 | 2007-12-26 | Northfield Lab | POLYMERIZED HEMOGLOBIN SOLUTIONS WITH REDUCED TETRAMER QUANTITY AND MANUFACTURING METHOD |
US7135554B1 (en) * | 2004-01-27 | 2006-11-14 | Biopure Corporation | Method of forming a polymerized hemoglobin solution from stabilized hemoglobin |
JP5346468B2 (ja) | 2004-10-29 | 2013-11-20 | シーラス コーポレイション | 赤血球不活性化プロセスのための改善されたクエンチング方法 |
WO2007065265A1 (en) | 2005-12-08 | 2007-06-14 | Ronald Kluger | Cross-linking reagents for hemoglobin and hemoglobin products cross-linked therewith |
US7759306B2 (en) | 2006-05-16 | 2010-07-20 | Simoni Jan S | Methods of treating acute blood loss |
US7795401B2 (en) | 2006-09-06 | 2010-09-14 | National Chung Cheng University | Modified hemoglobin with allosteric effector conjugated |
CN101168565A (zh) * | 2006-10-23 | 2008-04-30 | 爱科有限公司 | 一氧化氮阻断的交联四聚体血红蛋白 |
US7494974B2 (en) | 2006-10-24 | 2009-02-24 | Ikor, Inc. | Carboxymethylated cross-linked tetrameric hemoglobin |
US7932356B1 (en) | 2010-06-23 | 2011-04-26 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
-
2011
- 2011-04-11 US US13/083,639 patent/US7989593B1/en not_active Expired - Fee Related
- 2011-04-15 CN CN2011800012855A patent/CN102405051B/zh active Active
- 2011-04-15 DK DK11746429.7T patent/DK2411025T3/en active
- 2011-04-15 PL PL11746429T patent/PL2411025T3/pl unknown
- 2011-04-15 AU AU2011221433A patent/AU2011221433B2/en active Active
- 2011-04-15 PT PT117464297T patent/PT2411025E/pt unknown
- 2011-04-15 JP JP2012517937A patent/JP5261806B2/ja active Active
- 2011-04-15 KR KR1020117020242A patent/KR101185437B1/ko active IP Right Grant
- 2011-04-15 EP EP11746429.7A patent/EP2411025B1/en active Active
- 2011-04-15 NZ NZ594915A patent/NZ594915A/xx unknown
- 2011-04-15 ES ES11746429.7T patent/ES2527608T3/es active Active
- 2011-04-15 SG SG2011062502A patent/SG182237A1/en unknown
- 2011-04-15 CN CN201310054976.2A patent/CN103169954B/zh not_active Expired - Fee Related
- 2011-04-15 WO PCT/US2011/032594 patent/WO2011149602A1/en active Application Filing
- 2011-04-15 CA CA2752943A patent/CA2752943C/en active Active
- 2011-04-15 RU RU2011136158/15A patent/RU2475252C1/ru not_active IP Right Cessation
- 2011-04-29 TW TW100115051A patent/TWI377947B/zh active
- 2011-05-24 SA SA111320476A patent/SA111320476B1/ar unknown
- 2011-05-24 AR ARP110101773A patent/AR081222A1/es unknown
-
2012
- 2012-02-02 HK HK12100981.7A patent/HK1160604A1/zh unknown
- 2012-07-10 HK HK12106776.3A patent/HK1166258A1/xx not_active IP Right Cessation
- 2012-11-20 ZA ZA2012/08726A patent/ZA201208726B/en unknown
-
2015
- 2015-02-04 CY CY20151100114T patent/CY1115986T1/el unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618919A (en) * | 1986-11-10 | 1997-04-08 | Biopure Corportion | Ultra pure hemoglobin solutions and blood-substitutes |
US6150506A (en) * | 1989-05-10 | 2000-11-21 | Baxter Biotech Technology Sarl | Modified hemoglobin-like compounds and methods of purifying same |
US5250665A (en) * | 1991-05-31 | 1993-10-05 | The University Of Toronto Innovations Foundation | Specifically β-β cross-linked hemoglobins and method of preparation |
US7041800B1 (en) * | 1995-03-23 | 2006-05-09 | Biopure Corporation | Preserving a hemoglobin blood substitute with a transparent overwrap |
US20100035797A1 (en) * | 2006-10-23 | 2010-02-11 | IKOR Inc., a South Dakota Corporation | Nitric oxide-blocked cross-linked tetrameric hemoglobin |
Non-Patent Citations (1)
Title |
---|
LU,XL ET AL: "Disuccinimidyl suberate cross-linked hemoglobin as a novel red blood cell substitute", 《SCIENCE IN CHINA SERIES C-LIFE SCIENCES》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104717966A (zh) * | 2012-10-12 | 2015-06-17 | 视界全球控股有限公司 | 用于癌症靶向治疗和预防癌症复发的含有基于血红蛋白的氧载体的药物组合物 |
CN104717966B (zh) * | 2012-10-12 | 2018-08-24 | 视界全球控股有限公司 | 用于癌症靶向治疗和预防癌症复发的含有基于血红蛋白的氧载体的药物组合物 |
CN103251998A (zh) * | 2012-11-08 | 2013-08-21 | 黄炳镠 | 用于血红蛋白氧载体(hboc)溶液的精确输注递送系统 |
CN103251998B (zh) * | 2012-11-08 | 2015-09-02 | 亿京国际有限公司 | 用于血红蛋白氧载体(hboc)溶液的精确输注递送系统 |
CN106421805A (zh) * | 2016-09-14 | 2017-02-22 | 中国人民解放军军事医学科学院野战输血研究所 | 一种右旋糖酐交联血红蛋白氧载体及其制备方法与应用 |
CN106421805B (zh) * | 2016-09-14 | 2019-06-04 | 中国人民解放军军事医学科学院野战输血研究所 | 一种右旋糖酐交联血红蛋白氧载体及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
AR081222A1 (es) | 2012-07-04 |
SA111320476B1 (ar) | 2013-07-28 |
CA2752943A1 (en) | 2011-11-27 |
WO2011149602A8 (en) | 2012-05-24 |
SG182237A1 (en) | 2012-08-30 |
DK2411025T3 (en) | 2015-02-16 |
EP2411025A1 (en) | 2012-02-01 |
HK1166258A1 (en) | 2012-10-26 |
ZA201208726B (en) | 2013-09-25 |
WO2011149602A1 (en) | 2011-12-01 |
CA2752943C (en) | 2013-10-08 |
JP2012526859A (ja) | 2012-11-01 |
NZ594915A (en) | 2013-06-28 |
CN103169954A (zh) | 2013-06-26 |
KR20110138215A (ko) | 2011-12-26 |
US7989593B1 (en) | 2011-08-02 |
KR101185437B1 (ko) | 2012-10-02 |
PT2411025E (pt) | 2015-02-04 |
JP5261806B2 (ja) | 2013-08-14 |
AU2011221433B2 (en) | 2012-03-29 |
CN103169954B (zh) | 2016-01-20 |
AU2011221433A1 (en) | 2011-12-15 |
TW201141493A (en) | 2011-12-01 |
EP2411025A4 (en) | 2012-11-14 |
RU2475252C1 (ru) | 2013-02-20 |
CN102405051B (zh) | 2013-01-23 |
TWI377947B (en) | 2012-12-01 |
CY1115986T1 (el) | 2017-01-25 |
PL2411025T3 (pl) | 2015-04-30 |
EP2411025B1 (en) | 2014-11-05 |
HK1160604A1 (zh) | 2012-08-10 |
ES2527608T3 (es) | 2015-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102405051B (zh) | 一种制备高温稳定的包含氧载体的药物组合物的方法及其应用 | |
CN102510753B (zh) | 一种制备热稳定的包含氧载体的组合物的方法 | |
KR101121102B1 (ko) | 열 안정성 산소 운반체 함유 약학 조성물의 제조 방법 | |
JP6148673B2 (ja) | β‐β架橋を容易にする熱安定性酸素担体含有組成物の調製方法 | |
CN103687609B (zh) | 用于不同治疗应用的含热稳定氧载体的药物组合物 | |
JP2010507679A (ja) | 酸化窒素ブロック型架橋四量体ヘモグロビン | |
KR20140031915A (ko) | 고온 단기 열처리 기구로 변형되지 않은 헤모글로빈을 중합 헤모글로빈을 포함하는 상호결합된 헤모글로빈 용액으로부터 제거하는 방법 | |
US8742073B2 (en) | Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof | |
US20130219829A1 (en) | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1166258 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FENGAN INTERNATIONAL CO., LTD. Free format text: FORMER OWNER: HUANG BING Effective date: 20130305 Free format text: FORMER OWNER: GUO RUIYI Effective date: 20130305 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; TO: HONG KONG, CHINA |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130305 Address after: Room 23, building 2301, Fu Hui business centre, 27 Li Fu Street, Sheung Wan, Hongkong, China Patentee after: Feng an International Limited Address before: American California Patentee before: Huang Bingliao Patentee before: Guo Ruiyi |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1166258 Country of ref document: HK |